The Report Guru

According to research report the global Genome Engineering Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. In 2017, North America is projected to have the highest growth rate during the forecast period. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America. The global genome editing market

  According to research report Healthcare Middleware Market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258951459 Increasing utilization of smart devices, availability of big data in healthcare, increasing need for data interoperability, and growing investments to overcome healthcare interoperability issues are the key drivers of the global market for middleware in healthcare. In 2018, North America to dominate the healthcare middleware market In 2018, North America is expected to command the largest share of the market, followed by Europe, Asia, and the Rest of the World. The large share of North America is attributed to factors such as the implementation of federal health mandates to encourage the adoption of HCIT solutions, rising pressure to curb healthcare costs, increasing investment to improve data interoperability, and the growin

  According to the new market research Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350 The key factors driving the growth of this market include increasing prevalence of cancer, initiatives undertaken by government and global health organizations, increasing preference for non-invasive procedures, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D. North America is expected to dominate the market in 2017 North America is expected to account for the largest share of the liquid biopsy market in 2017, followed by Europe. A number of factors such as the easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, rising prevalence of cancer in the US

  According to research report wearable healthcare devices market size is projected to reach USD 46.6 billion by 2025 from USD 18.4 billion in 2020, at a CAGR of 20.5% from 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=81753973 This market is largely driven by the increasing awareness of fitness and healthy lifestyles, development of technologically advanced products, growing geriatric population and subsequent increase in the incidence of chronic diseases, cost-containment in healthcare delivery, robust penetration of 3G and 4G networks for uninterrupted healthcare services, increasing penetration of smartphones and the growing number of smart-phone based healthcare apps and growing preference for wireless connectivity among healthcare providers are driving the growth of the global wearable healthcare devices industry. Growing adoption of mobile platforms, increasing adoption of AI and 5G, and the growing awareness &

  According to research report the global Genome Engineering Market is projected to reach USD 6.28 billion by 2022 from USD 3.19 billion in 2017, at a CAGR of 14.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 The key factors propelling the growth of this genome editing market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. In 2017, North America is projected to have the highest growth rate during the forecast period. Factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding are propelling market growth in North America. The global genome editing mark

 According to market research report the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392 North America is the largest regional market for coagulation analyzers North America (comprising the US and Canada) accounted for the largest share of the global Coagulation Analyzer Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America. Clinical laboratory analyzers dominated the Coagulation Analyzer Market in 2019 Based on product, the Hemostasis Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market. The

  According to research report the global In Vitro Diagnostics Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582 Key players are focusing on increasing their presence in this growing market through both organic as well as inorganic growth strategies, such as product launches, agreements, partnerships, collaborations, and expansions. Due to the intense competition in the In Vitro Diagnostics Quality Control Market, various market players are increasingly focusing on expanding their geographic presence in high-growth emerging markets. Bio-Rad Laboratories Inc. (US) was the leading player in the In Vitro Diagnostics Quality Control Market and accounted for the largest share in 2018. The company is a leading provider of clinical diagnostic systems, analytical devices, and instruments. The company

  According to the new market research report Immunoassay Market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 The increasing incidence of chronic and infectious diseases, technological advancements in immunoassay instruments and introduction of novel automated systems, and growth in the biotechnology and biopharmaceutical industries are some the major factors driving the growth of this market. North America held the largest share of the market in 2017 Based on region, the immunoassay market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2017. The large share of this regional segment is attributed to the increasing incidence of chronic diseases and improved healthcare infrastructure. The chemiluminescence immunoassays (CLIAs) segment led the imm

  According to research report Weight Loss Management Market is estimated to reach USD 245.51 Billion by 2022 from USD 175.94 Billion in 2017, at a CAGR of 6.9%. Ask For Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152 The growth of this Weight Loss Management Market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries. North America to dominate the weight loss and weight management market In 2017, North America is expected to dominate the global Weight Loss Management Market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region. In 2017, Europe is expected to account for the second-largest share of this market. Rising prevalence of obesity and increasing government support and initiatives to tackle obesit

  According to the new market research report Life Science Analytics Market is expected to reach 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period of 2020 to 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653 Growth in this life science analytics software market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales & marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent The life science analytics market is a highly diversified and competitive market, with a large number of players, including

According to research report the global cancer biomarkers market to reach USD 20.4 billion by 2022. and is estimated to grow at a CAGR of 12.2% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market. North America was the largest regional market for cancer biomarkers in 2016 North America accounted for the largest share of the cancer biomarkers market in 2017, followed by Europe. North America is the largest market for cancer biomarkers majorly due to government support (in the US and Canada) for the discovery and development of biomarkers, rising use of biomarkers in drug discovery and development by pharmaceutical companies, adoption of

According to the new market research report the global remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492 The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, growing incidences of chronic diseases, and increasing investments in telehealth and RPM are the major factors driving the growth of this market. However, the regulatory variations across regions, healthcare fraud, and informal usage of social media practices is expected to restrain the market growth during the forecast period. The prominent players operating in the remote patient monitoring market include BioTelemetry Inc. (US), Koninklijke Philips N

 According to the new market research report Spatial Genomics Market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551 The market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications in biomarker identification and drug discovery & development, and increasing investment in biopharmaceutical R&D. Spatial Transcriptomics techniques accounted for the largest share of the spatial genomics market Based on the technique, the spatial genomics and transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. In 2019, the spatial transcriptomics techniques segment accounted for the largest share of the global spatial genomics market. Growth in this market s

According to research report the Blood Gas and Electrolyte Analyzer Market was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021. Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of the blood gas analyzer market in the coming years. The other factors driving the growth of Blood Gas and Electrolyte Analyzer Market include rising geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing adoption of technologically advanced biosensors and data analysis software, growing demand for technology integrated combined systems, an

  According to research report Extracorporeal Membrane Oxygenation Machine Market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. Ask For Free PDF Brochure : http://www.marketsandmarkets.com/pdfdownload.asp?id=255167654 A number of factors such as the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to heart & lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements are the significant factors driving the growth of the Extracorporeal Membrane Oxygenation Machine Market. In addition, the growing aging population and the number of people suffering from cardiopulmonary diseases in populous countries such as India and China are factors that are expected to offer significant growth opportunities for ECMO systems. Complications associated with ECMO • Bleeding: This is the most common complication associated

 According to the new market research report RSV Diagnostics Market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95683942 Factors driving the growth of this market include rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. North America is estimated to command the largest share of the market during the forecast period. Based on region, the Respiratory Syncytial Virus Diagnostics Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the RSV diagnostics market in 2017. This is mainly due to factors such as the increasing patient base of RSV diseases, technological advancements in PoC molecular diagnostic devices, and growing healthcare expen

  According to the new market research report eHealth Market is expected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143 Factors such as the growing need to manage regulatory compliance through the use of eHealth solutions, the need to curtail escalating healthcare costs, increasing government initiatives supporting the use of eHealth solutions and services, the high prevalence of chronic diseases, shift towards patient-centric healthcare delivery, and rising usage of big data are majorly driving the growth of this market. he Asia Pacific region is expected to register the highest growth rate in the global eHealth market during the forecast period. Growing medical tourism, growing consumerism in the healthcare industry, accelerated economic growth of countries in the region, the implementation of new ICT guidelines, and the implementation of eHeal

  According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894 Market growth factors such as increasing adoption of target therapy over traditional therapy, emergence of biosimilars, increasing demand for mAbs, high prevalence of cancer. Cancer immunotherapy drugs are designed to alter or boost the body’s natural immune response to fight cancer this market is research-driven with a high degree of dependence on the discovery of molecules that can generate an immune response against various indications. Based on regions, the global Cancer Immunotherapy market is segmented into North America, APAC, Europe and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors s

  According to research report the sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 High prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries are the key factors driving the growth of this market. In 2018, North America is expected to dominate the sinus dilation devices market followed by Europe. The large share of this geographical segment is attributed to rapidly increasing geriatric population, rising prevalence of chronic sinusitis, higher adoption of new technologies among ENT surgeons and otolaryngologists, favorable reimbursement scenario, and the presence of major players in this region. Balloon sinus d

 According to research report Surgical Microscopes Market is poised to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, at a CAGR of 12.5% from 2016 to 2021. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179225920 The increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions are the key factors driving the growth of the global surgical microscopes market. North America and Europe are established markets for surgical microscopes, due to broad technical applications of surgical microscopes and improved healthcare facilities in the region. However, Asia-Pacific is expected to show high growth rate in next few years in global operating microscopes market. This is due to presence of immense potential associated with healthcare services and increased investment in R

According to the new market research report Clinical Microbiology Market is estimated to be USD 3.9 billion in 2020 and projected to reach USD 5.3 billion by 2025, at a CAGR of 6.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367 Factors such as the Technological advancements, rising incidence of infectious diseases and growing outbreak of epidemics (such as COVID-19), and increased funding and public-private investments are some of the key factors driving the growth of the microbiological testing/clinical microbiology market. bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US) are some of the major players in the clinical microbiology market among others. The analysis of market d

 According to market research report Veterinary Dental Equipment Market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837 Growth in the global companion animal population, the rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the Veterinary Dentistry Equipment Market during the forecast period. Recent Developments - In 2018, Dispomed (US) launched Highdent Quattro Plus, its latest in veterinary dental units. In 2018, Eickemeyer (Germany) signed a partnership agreement with Central CPD (UK) to connect with veterinary practitioners through professional training programs and promote the latest medical equipment. In 2015, Henry Schein (US) acquired Jorgen Kruuse A/S (Denmark) t

  According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243344814 A pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally. When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias. A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias. Recent Developments: • In November 2017, Medtronic received FDA approval and launched the Azure pacemaker with BlueSync technology in the US market • In February 2017, Medtronic received CE Mark certification for its Next Generation Cardiac Resynchronization Therapy-Pacemakers • In February 2017, Abbott Laboratories received FDA approval for the Assurit